MicroRNA-939 Directly Targets HDGF to Inhibit the Aggressiveness of Prostate Cancer via Deactivation of the WNT/β-Catenin Pathway [Retraction]

MicroRNA-939 Directly Targets HDGF to Inhibit the Aggressiveness of Prostate Cancer via Deactivation of the WNT/β-Catenin Pathway [Retraction]

Situ J, Zhang H, Jin Z, Li K, Mao Y, Huang W. Onco Targets Ther. 2020;13:4257–4270. The Editor and Publisher of OncoTargets and Therapy wish to retract the published article. Concerns were raised over alleged image duplication in Figure 8A with similar images from unrelated articles, speci...

Full description

Bibliographic Details
Main Authors: Situ J, Zhang H, Jin Z, Li K, Mao Y, Huang W
Format: Article
Language:English
Published: Dove Medical Press 2021-10-01
Series:OncoTargets and Therapy
Subjects:
microrna-939
prostate cancer
hepatoma-derived growth factor
wnt/β-catenin signaling
Online Access:https://www.dovepress.com/retraction-microrna-939-directly-targets-hdgf-to-inhibit-the-aggressiv-peer-reviewed-fulltext-article-OTT

Internet

https://www.dovepress.com/retraction-microrna-939-directly-targets-hdgf-to-inhibit-the-aggressiv-peer-reviewed-fulltext-article-OTT

Similar Items